Intellectual property law and access to medicines TRIPS Agreement, health, and pharmaceuticals
Introduction -- World Trade Organization : a barrier to global public health? / Srividhya Ragavan -- World Health Organization : contributions to access to health and TRIPS agreement discourse / Susan Isiko Štrba -- From TRIPS to access to medicines : what's there in between? / Sergio Napolitan...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | UnknownFormat |
| Sprache: | eng |
| Veröffentlicht: |
London, New York, NY
Routledge, Taylor & Francis Group
2021
|
| Schriftenreihe: | Law, development and globalization
|
| Schlagworte: |
Agreement on Trade-Related Aspects of Intellectual Property Rights
> Drug accessibility
> Law and legislation
> Foreign trade regulation
> Health aspects
> Drugs
> Patents
> Patents (International law)
> Konferenzschrift
> Aufsatzsammlung
> Accord sur les aspects des droits de propriété intellectuelle qui touchent au commerce : 1994
> Arzneimittel
> Recht
|
| Online Zugang: | Inhaltsverzeichnis |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Tag hinzufügen | Zusammenfassung: | Introduction -- World Trade Organization : a barrier to global public health? / Srividhya Ragavan -- World Health Organization : contributions to access to health and TRIPS agreement discourse / Susan Isiko Štrba -- From TRIPS to access to medicines : what's there in between? / Sergio Napolitano -- Free trade agreements : longer, further, deeper impact on pharmaceutical patents / Bryan Mercurio -- From the TPP to USMCA : a high-powered battle over biologics / Burcu Kilic -- African union continental free trade area : opportunities for new regional discourse? / J. Janewa Osei-Tutu -- U.S. litigated government funded patents in Europe and Japan : a first look / Teo Firpo and Michael S. Mireles -- Brazil : patent barriers and access to medicine through public health system / Gabriela Costa Chaves, Maria Auxiladora Oliveira, and Jorge Antonio Zepeda Bermudez -- China : from struggle to surge : China's TRIPS experience and its lessons for access to medicines / Peter K. Yu -- Canada : access to medicine in high-income countries / Gaëlle Groux and Jeremy de Beer -- India : pharmaceutical patents and evergreen battle for access to medicine / Anand Grover -- South Africa's three decades of access to medicine discourse : blight or benefit / Caroline B. Ncube -- Thailand : shooting star for access to medicine through compulsory licensing / Van Anh Le -- United States : unilateral norm setting using Special 301 / Michael Palmedo -- Access to medicines activism : collaboration, conflicts, and complementarities / Brook K. Baker -- GTPI : experiences to overcome ip barriers to increase access to medicine / Felipe de Carvalho Borges da Fonseca, Marcela Fogaça Vieira, and Pedro Villardi -- Private sector : right to health responsibilities of pharmaceutical companies / Emmanuel Kolawole Oke -- Competition : can excessive pricing be fixed through abuse of dominant position? / Shirin Syed -- The unique world of pharmaceutical intellectual property rights / Emily Michiko Morris -- Innovation policies : roadblocks to establishing sustainable pharmaceutical innovation policies / Doris Estelle Long -- Not Just patents and data exclusivity : the role of trademarks in integrated IP strategy -where lies the public interest? / Graham Dutfield -- Indigenous knowledge : bridging with modern medicine / Anthony C. K. Kakooza -- Digital divide and access to medicine : the debate / Swaraj Paul Barooah -- Lessons from COVID-19 for medicine access / Amaka Vanni. "The history of patent harmonization is a story of dynamic actors, whose interactions with established structures shaped the patent regime. From the inception of the trade regime to include intellectual property rights to the present, this book documents the role of different sets of actors - such as states, transnational business corporations or civil society groups - and their influence on the structures - such as national and international agreements, organizations and private entities - that have caused changes to healthcare and access to medication. Presenting the debates over patents, trade and TRIPS, as it galvanized non-state and non-business actors, the book highlights how an alternative framing and understanding of pharmaceutical patent rights emerged: as a public issue, instead of a trade or IP issue. The book thus offers an important analysis of the legal and political dynamics through which the contest for access to life-saving medication has been, and will continue to be, fought. In addition to academics working in the areas of international law, development, and public health, this book will also be of interest to policy makers, state actors and others with relevant concerns working in non-governmental and international organizations"-- |
|---|---|
| Beschreibung: | Includes bibliographical references and index |
| Beschreibung: | xviii, 503 pages |
| ISBN: | 9780367436384 978-0-367-43638-4 9781032009704 978-1-032-00970-4 |